Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis

INTRODUCTION: Angiogenesis is an important factor in the development of osteoarthritis (OA). We investigated the efficacy of bevacizumab, an antibody against vascular endothelial growth factor and an inhibitor of angiogenesis, in the treatment of OA using a rabbit model of anterior cruciate ligament...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nagai, Toshihiro, Sato, Masato, Kobayashi, Miyuki, Yokoyama, Munetaka, Tani, Yoshiki, Mochida, Joji
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4189677/
https://ncbi.nlm.nih.gov/pubmed/25230745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-014-0427-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky